Fundraising FoxPronovotx
2 known investors
Find your way into Pronovotx
Sign up to see every warm intro you have to Pronovotx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pronovotx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ProNovo Therapeutics is a biotechnology company developing precision small-molecule therapeutics for neuropsychiatric disorders, including Major Depressive Disorder and Schizophrenia. The company applies a precision-medicine approach based on genetic susceptibility, disease pathophysiology, and biomarkers to advance preclinical drug programs toward clinical development.
Founders & leadership
Investors · 2
3E Bioventures Capital✓ confirmed by PronovotxPalo Alto
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Pronovotx do?
- ProNovo Therapeutics is a biotechnology company developing precision small-molecule therapeutics for neuropsychiatric disorders, including Major Depressive Disorder and Schizophrenia. The company applies a precision-medicine approach based on genetic susceptibility, disease pathophysiology, and biomarkers to advance preclinical drug programs toward clinical development.
- Who founded Pronovotx?
- Pronovotx was founded by Guang Chen, Xiaohu Deng, Scott Thompson.
- Who are Pronovotx's investors?
- Pronovotx's investors include 3E Bioventures Capital, Gaorong Ventures.